Yoshida T, Yoshimura A, Ono M, Hori S, Waki M, Kuwano M
Department of Biochemistry, Oita Medical School, Japan.
Biochim Biophys Acta. 1987 Oct 17;921(3):575-86.
Mutants resistant to compactin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, have been previously isolated from the Chinese hamster V79 cell line. Two compactin-resistant mutants, MF-1 and MF-2, show altered responses to human low-density lipoprotein (LDL). Accumulation of fluorescent-labeled LDL was much reduced. Ligand blotting showed LDL receptor activity in MF-1 and MF-2 cells of about one half to one third that of V79. Internalization and degradation of LDL in MF-1 or MF-2 cells were about one tenth those in V79 cells, suggesting that the LDL binding as well as the LDL internalization of the compactin-resistant clones was altered. Down-regulation of LDL receptor activity as well as hydroxymethylglutaryl CoA reductase was observed in V79 cells treated with LDL, while there appeared to be much less down-regulation in MF-1 and MF-2 cells. Using anti-LDL receptor antibody, MF-1 and MF-2 cells were found to produce smaller-sized mature forms of LDL receptor: the molecular mass of the mutant LDL receptor was 3-5 kDa smaller than that of the parental LDL receptor. Altered O-linked oligosaccharides or amino acid sequence might account for the decreased molecular mass and aberrant properties of the LDL receptor in MF-1 and MF-2.
对3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂美伐他汀具有抗性的突变体,此前已从中国仓鼠V79细胞系中分离出来。两个美伐他汀抗性突变体MF-1和MF-2,对人低密度脂蛋白(LDL)的反应发生了改变。荧光标记的LDL积累量大幅减少。配体印迹显示MF-1和MF-2细胞中的LDL受体活性约为V79细胞的二分之一到三分之一。MF-1或MF-2细胞中LDL的内化和降解约为V79细胞的十分之一,这表明美伐他汀抗性克隆的LDL结合以及LDL内化都发生了改变。在用LDL处理的V79细胞中观察到LDL受体活性以及羟甲基戊二酰辅酶A还原酶的下调,而在MF-1和MF-2细胞中下调似乎要少得多。使用抗LDL受体抗体,发现MF-1和MF-2细胞产生的LDL受体成熟形式尺寸较小:突变型LDL受体的分子量比亲本LDL受体小3至5 kDa。O-连接寡糖或氨基酸序列的改变可能解释了MF-1和MF-2中LDL受体分子量的降低和异常特性。